ANTIGEN COMPONENT by Sanofi Pasteur Inc. ANTIGEN COMPONENT

ANTIGEN COMPONENT by

Drug Labeling and Warnings

ANTIGEN COMPONENT by is a Other medication manufactured, distributed, or labeled by Sanofi Pasteur Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ANTIGEN COMPONENT- cov-2 pres dtm antigen injection, emulsion 
Sanofi Pasteur Inc.

----------

ANTIGEN COMPONENT

Health Care Professional and Patient Fact Sheets are not available at this time.

PRINCIPAL DISPLAY PANEL - 10 Dose Vial Label

NDC: 49281-618-78
Vial 1 of 2
ANTIGEN COMPONENT
for Sanofi Pasteur COVID-19 Vaccine, Adjuvanted

After mixing, emulsion for intramuscular injection
For use under Emergency Use Authorization.
NOT TO BE USED ALONE.
Add 1 vial of AS03 Adjuvant Component to form the Vaccine.
Multiple Dose Vial (after mixing, contains 10 doses of 0.5 mL). After
mixing, hold at 23°C to 27°C (73°F to 80°F). Discard after 6 hours.
Refer to FDA-authorized Fact Sheet for mixing instructions.
No Preservative
Record date and time of mixing:
Manufactured by: Sanofi Pasteur Inc.

PRINCIPAL DISPLAY PANEL - 10 Vial Label

PRINCIPAL DISPLAY PANEL - 10 Vial Carton

NDC: 49281-618-20
ANTIGEN COMPONENT
for Sanofi Pasteur COVID-19 Vaccine, Adjuvanted

After mixing, emulsion for intramuscular injection
For use under Emergency Use Authorization

CONTENTS: 10 Multiple Dose Vials (after mixing with AS03 Adjuvant Component,
each vial contains ten 0.5 mL doses of Vaccine)

NOTICE: NOT TO BE USED ALONE
One vial of AS03 Adjuvant Component MUST BE ADDED to one vial of
Antigen Component to form the Vaccine.

794426

SANOFI PASTEUR

PRINCIPAL DISPLAY PANEL - 10 Vial Carton
ANTIGEN COMPONENT 
cov-2 pres dtm antigen injection, emulsion
Product Information
Product TypeVACCINEItem Code (Source)NDC: 49281-618
Route of AdministrationINTRAMUSCULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COV-2 PRES DTM ANTIGEN (UNII: 76SQ8FDG7I) (COV-2 PRES DTM ANTIGEN - UNII:76SQ8FDG7I) COV-2 PRES DTM ANTIGEN50 ug  in 2.5 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) 22 mg  in 2.5 mL
SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE (UNII: E1W4N241FO) 6.5 mg  in 2.5 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) 0.975 mg  in 2.5 mL
POLYSORBATE 20 (UNII: 7T1F30V5YH) 13.75 mg  in 2.5 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 49281-618-2010 in 1 CARTON
1NDC: 49281-618-782.5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER11/10/202011/11/2020
Labeler - Sanofi Pasteur Inc. (086723285)
Establishment
NameAddressID/FEIBusiness Operations
Sanofi Pasteur Inc.086723285MANUFACTURE(49281-618)

Revised: 10/2024
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.